title: Betacellulin-Pseudomonas toxin fusion proteins bind but are not cytotoxic to cells expressing HER4; correlation of EGFR for cytotoxic activity.
abstract: Betacellulin (BTC) is a member of the EGF ligand family that directly binds to both EGFR and HER4 and induces the growth of certain epithelial cell types. Fusion proteins composed of the terminal 48 or 50 amino acids of mature betacellulin and a binding defective form of Pseudomonas exotoxin (BTC-TX48 and BTC-TX50, respectively), have been produced. BTC-TX50 induced tyrosine phosphorylation of both EGFR and HER4, whereas BTC-TX48 induced phosphorylation of HER4 but to a much lesser extent EGFR, indicating that the presence of two additional amino acid residues, Arg62 and Lys63, contribute to full kinase activity. BTC-TX50 was up to 300-fold more active at inhibiting protein synthesis than BTC-TX48 on cell lines expressing EGFR, most likely due to the >tenfold higher affinity of BTC-TX50. MDA-MB-453 breast carcinoma cells which express HER4 but not EGFR, were not sensitive to either BTC-TX form. These data indicate that despite the ability of BTC-TX to bind and phosphorylate HER4, it was only cytotoxic to cells expressing EGFR. The inability of BTC-TX to kill cells was likely due to its failure to internalize through HER4.
authors.affiliation: Molecular Immunology Department, Bristol-Myers Squibb, Pharmaceutical Research Institute, Seattle, Washington 98121, USA.
authors.forename: B
authors.initials: B
authors.lastname: Mixan
authors.forename: B D
authors.initials: BD
authors.lastname: Cohen
authors.forename: S S
authors.initials: SS
authors.lastname: Bacus
authors.forename: H P
authors.initials: HP
authors.lastname: Fell
authors.forename: C B
authors.initials: CB
authors.lastname: Siegall
mesh_terms: D016475:3T3 Cells; D000595:Amino Acid Sequence; D000818:Animals; D001427:Bacterial Toxins / Q000737:chemistry / Q000493:pharmacokinetics* / Q000633:toxicity*; D066259:Betacellulin; D001943:Breast Neoplasms; D002294:Carcinoma, Squamous Cell; D002470:Cell Survival / Q000187:drug effects; D066246:ErbB Receptors / Q000096:biosynthesis / Q000187:drug effects / Q000502:physiology*; D005260:Female; D006133:Growth Substances / Q000737:chemistry / Q000493:pharmacokinetics* / Q000633:toxicity*; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D007624:KB Cells; D016393:Lymphoma, B-Cell; D051379:Mice; D008969:Molecular Sequence Data; D010051:Ovarian Neoplasms; D011549:Pseudomonas; D066247:Receptor, ErbB-4; D011993:Recombinant Fusion Proteins / Q000737:chemistry / Q000493:pharmacokinetics / Q000633:toxicity; D014407:Tumor Cells, Cultured
chemical_list: C587851:BTC protein, human; D001427:Bacterial Toxins; D066259:Betacellulin; C587852:Btc protein, mouse; D006133:Growth Substances; D036341:Intercellular Signaling Peptides and Proteins; D011993:Recombinant Fusion Proteins; C587689:ERBB4 protein, human; D066246:ErbB Receptors; C587690:Erbb4 protein, mouse; D066247:Receptor, ErbB-4